Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Receivables - Other: 2012-2024

Historic Receivables - Other for Capricor Therapeutics (CAPR) over the last 11 years, with Dec 2024 value amounting to $10.4 million.

  • Capricor Therapeutics' Receivables - Other fell 85.56% to $59,167 in Q3 2025 from the same period last year, while for Sep 2025 it was $59,167, marking a year-over-year decrease of 85.56%. This contributed to the annual value of $10.4 million for FY2024, which is 0.03% down from last year.
  • Per Capricor Therapeutics' latest filing, its Receivables - Other stood at $10.4 million for FY2024, which was down 0.03% from $10.4 million recorded in FY2023.
  • Capricor Therapeutics' 5-year Receivables - Other high stood at $10.4 million for FY2023, and its period low was $391,750 during FY2021.
  • In the last 3 years, Capricor Therapeutics' Receivables - Other had a median value of $10.4 million in 2024 and averaged $7.1 million.
  • Per our database at Business Quant, Capricor Therapeutics' Receivables - Other spiked by 1,794.15% in 2023 and then declined by 0.03% in 2024.
  • Yearly analysis of 4 years shows Capricor Therapeutics' Receivables - Other stood at $391,750 in 2021, then surged by 39.78% to $547,580 in 2022, then spiked by 1,794.15% to $10.4 million in 2023, then fell by 0.03% to $10.4 million in 2024.